Portuguese, A. J., Huang, J. J., Jeon, Y., Taheri, M., Albittar, A., Liang, E. C., . . . Gauthier, J. (2025). Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: An inverse probability of treatment weighting analysis with 3-year follow up. Haematologica (Roma), 110(9), 2040-2054. https://doi.org/10.3324/haematol.2024.287010
Citace podle Chicago (17th ed.)Portuguese, Andrew J., et al. "Real-world Comparison of Lisocabtagene Maraleucel and Axicabtagene Ciloleucel in Large B-cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis with 3-year Follow Up." Haematologica (Roma) 110, no. 9 (2025): 2040-2054. https://doi.org/10.3324/haematol.2024.287010.
Citace podle MLA (9th ed.)Portuguese, Andrew J., et al. "Real-world Comparison of Lisocabtagene Maraleucel and Axicabtagene Ciloleucel in Large B-cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis with 3-year Follow Up." Haematologica (Roma), vol. 110, no. 9, 2025, pp. 2040-2054, https://doi.org/10.3324/haematol.2024.287010.